手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| ハミルトンうつ病評価尺度 (HAM-D)× | 迅速抑うつ症状評価尺度 (QIDS)× | |
|---|---|---|
| 分野 | 臨床心理学 | 臨床心理学 |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 1960 | 2003 |
| 提唱者≠ | Max Hamilton | A. John Rush |
| 種類≠ | Clinician-rated interview scale | Self-report or clinician-administered questionnaire |
| 原典≠ | Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery & Psychiatry, 23(1), 56–62. DOI ↗ | Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., & Ninan, P. T. (2003). The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54(5), 573–583. DOI ↗ |
| 別名 | HAM-D, HDRS, Hamilton Rating Scale for Depression | QIDS, Quick Inventory of Depressive Symptomatology-Self Report, QIDS-SR |
| 関連≠ | 5 | 4 |
| 概要≠ | The Hamilton Depression Rating Scale, published by Max Hamilton in 1960, is a clinician-administered interview assessment of depressive symptom severity. The most common version contains 17 items (HAM-D-17), though 21-item and 24-item versions exist. It is considered the gold standard outcome measure in antidepressant drug trials and remains the most cited depression rating scale in the psychiatric literature. Unlike self-report measures, HAM-D requires clinician judgment and observation, making it particularly valuable in research settings where standardized measurement by trained raters is essential. | The Quick Inventory of Depressive Symptomatology is a 16-item assessment designed by A. John Rush and colleagues to efficiently measure the severity of depressive symptoms in adults. Published in Biological Psychiatry in 2003, the QIDS exists in both self-report (QIDS-SR) and clinician-rated (QIDS-C) versions. It was developed as a brief alternative to the longer Inventory of Depressive Symptomatology (IDS, 30 items) while maintaining comprehensive coverage of DSM-IV depressive symptoms. The QIDS has become a standard outcome measure in treatment research, particularly in large comparative effectiveness trials. |
| ScholarGateデータセット ↗ |
|
|